Bioatla Valuation
| BCAB Stock | USD 0.34 0.04 10.53% |
Bioatla seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Bioatla from analyzing the firm fundamentals such as Operating Margin of (1.02) %, shares outstanding of 58.02 M, and Return On Equity of -1.39 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Bioatla's valuation include:
Price Book 0.8625 | Enterprise Value | Enterprise Value Ebitda 0.3052 | Price Sales 1.8009 | Enterprise Value Revenue 2.2459 |
Overvalued
Today
Please note that Bioatla's price fluctuation is out of control at this time. Calculation of the real value of Bioatla is based on 3 months time horizon. Increasing Bioatla's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bioatla is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bioatla Stock. However, Bioatla's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.34 | Real 0.33 | Target 9.0 | Hype 0.34 | Naive 0.42 |
The real value of Bioatla Stock, also known as its intrinsic value, is the underlying worth of Bioatla Company, which is reflected in its stock price. It is based on Bioatla's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bioatla's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bioatla helps investors to forecast how Bioatla stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bioatla more accurately as focusing exclusively on Bioatla's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Bioatla's intrinsic value based on its ongoing forecasts of Bioatla's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Bioatla's closest peers. If more than one evaluation category is relevant for Bioatla we suggest using both methods to arrive at a better estimate.
Bioatla Cash |
|
Bioatla Valuation Trend
Comparing Bioatla's enterprise value against its market capitalization is a good way to estimate the value of Bioatla uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Bioatla Total Value Analysis
Bioatla is currently forecasted to have valuation of (35.46 M) with market capitalization of 19.81 M, debt of 2.46 M, and cash on hands of 178.12 M. The negative valuation of Bioatla may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Bioatla fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(35.46 M) | 19.81 M | 2.46 M | 178.12 M |
Bioatla Asset Utilization
One of the ways to look at asset utilization of Bioatla is to check how much profit was generated for every dollar of assets it reports. Bioatla shows a negative utilization of assets of -0.5 percent, losing $0.005047 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Bioatla shows how discouraging it operates for each dollar spent on its assets.Bioatla Ownership Allocation
Bioatla holds a total of 58.02 Million outstanding shares. 30% of Bioatla outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Bioatla Profitability Analysis
Net Loss for the year was (123.46 M) with loss before overhead, payroll, taxes, and interest of (63.12 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bioatla's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bioatla and how it compares across the competition.
About Bioatla Valuation
The stock valuation mechanism determines Bioatla's current worth on a weekly basis. Our valuation model uses a comparative analysis of Bioatla. We calculate exposure to Bioatla's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bioatla's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -93.4 M | -88.7 M | |
| Pretax Profit Margin | (438.85) | (416.91) | |
| Operating Profit Margin | (443.62) | (421.44) | |
| Net Loss | (438.87) | (416.92) | |
| Gross Profit Margin | (4.97) | (4.72) |
Bioatla Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 47.8 M |
Bioatla Current Valuation Indicators
Valuation refers to the process of determining the present value of Bioatla and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Bioatla we look at many different elements of the entity such as Bioatla's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Bioatla, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Bioatla's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Bioatla's worth.Complementary Tools for Bioatla Stock analysis
When running Bioatla's price analysis, check to measure Bioatla's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioatla is operating at the current time. Most of Bioatla's value examination focuses on studying past and present price action to predict the probability of Bioatla's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioatla's price. Additionally, you may evaluate how the addition of Bioatla to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |